Mostrar 1 - 6 resultats de 6 per cerca 'Ilene Galinsky (15054032)', hora de la petició: 0.01sec Refinar resultats
  1. 1
    Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S1 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates per Evan C. Chen (15054014)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  2. 2
    Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S3 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates per Evan C. Chen (15054014)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  3. 3
    Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S4 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates per Evan C. Chen (15054014)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  4. 4
    Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S2 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates per Evan C. Chen (15054014)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  5. 5
    Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S6 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates per Evan C. Chen (15054014)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:
  6. 6
    Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates

    Figure S5 from Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates per Evan C. Chen (15054014)

    Publicat 2025
    Altres autors:
    Afegir a favorits
    Guardat en:

Eines de cerca: